Growth Stage

Making a Difference, Naturally.


Raised to Date: Raised: $3,958,302

Aggregate Commitments $


Dalmore Group

Start Date


Close Date


Min. Goal


Max. Goal


Min. Investment


Security Type

Equity - Common

Funding Type



Series A

Price Per Share


Pre-Money Valuation


*Note: Per the company's filings, up to 8.67% of the offering is being sold to existing shareholders.

Rolling Commitments $



Reporting Date


Days Remaining


% of Min. Goal


% of Max. Goal


Likelihood of Max
Avg. Daily Raise


Create a free account today to gain access to KingsCrowd analytics.

Canoga Park, California


Consumer Products, Goods & Services

Tech Sector


Distribution Model




Capital Intensity


Business Type


Med-X, with a pre-money valuation of $102 million, is raising funds on Dalmore via Regulation A+. The company has developed many all-natural and plant-based brands that are replacing chemicals to solve everyday issues. The products are sold through major retail and healthcare distributors. The flagship product lines of Med-X include Nature-Cide and Thermal-Aid. Med-X is led by Dr. David Toomey and Matthew Mills and was founded in 2014.

Balance Sheet

Cash and Cash Equivalents


Investment Securities


Accounts and Notes Receivable


Property, Plant and Equipment (PP&E)


Total Assets


Accounts Payable & Accrued Liabilities


Long Term Debt


Total Liabilities


Total Stockholders' Equity


Total Liabilities and Equity


Statement of Comprehensive Income Information

Total Revenues


Costs & Expenses Applicable to Rev


Depreciation and Amortization


Net Income


Earnings Per Share - Basic


Earnings Per Share - Diluted


Auditor: Prager Metis, CPA's LLP
Financials as of: 07/23/2021
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Med-X 12/31/2022 Dalmore Group $102,217,405 $3,958,302 Equity - Common Active RegA+
Med-X 09/10/2021 TruCrowd $88,552,772 $15,595 Equity - Common Funded RegCF
Med-X 06/27/2019 StartEngine - $0 Equity - Common Funded RegA+
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Med-X on Dalmore Group 2021
Platform: Dalmore Group
Security Type: Equity - Common
Valuation: $102,217,405
Invest in a different round for this company? Use my investment date to determine which raise I invested in.

Follow company

Follow Med-X on Dalmore Group 2021
View on Dalmore Group
Bullish / Bearish
You're Bullish on Med-X on Dalmore Group 2021

Thank you for your vote on Med-X on Dalmore Group 2021

Bullish / Bearish
You're Bearish on Med-X on Dalmore Group 2021

Thank you for your vote on Med-X on Dalmore Group 2021